However, mechanisms of the sex-specific association of LCAT and CV risk need further investigation given the conflicting results so far available, for instance in patients with sickle cell anemia and proteinuria where a less pronounced reduction of LCAT activity in women compared to men has been considered protective against accelerated kidney disease progression in this patient population (91). This evidence concerns the gene LCAT and sickle cell disease.